Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Retained Earnings (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Retained Earnings for 3 consecutive years, with -$1.1 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 194759.69% to -$1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 billion through Dec 2025, down 194759.69% year-over-year, with the annual reading at -$1.1 billion for FY2025, 194759.69% down from the prior year.
  • Retained Earnings for Q4 2025 was -$1.1 billion at Nuvation Bio, down from -$1.1 billion in the prior quarter.
  • The five-year high for Retained Earnings was $1.4 million in Q3 2024, with the low at -$1.1 billion in Q4 2025.
  • Average Retained Earnings over 3 years is -$269.0 million, with a median of -$2.1 million recorded in 2023.
  • The sharpest move saw Retained Earnings skyrocketed 216.57% in 2024, then tumbled 194759.69% in 2025.
  • Over 3 years, Retained Earnings stood at $181000.0 in 2023, then surged by 216.57% to $573000.0 in 2024, then crashed by 194759.69% to -$1.1 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$1.1 billion, -$1.1 billion, and -$1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.